- Contractors
- Public Health Vaccines LLC
Public Health Vaccines LLC
Federal contractor · Research and Development in Biotechnology (except Nanobiotechnology)
Public Health Vaccines has 1 federal contract of $100,000 or more active since October 2023, with $89M obligated, from 1 agency. 1 is still running.
- Contracts
- 1 since FY2024$89,026,883 obligated, contracts of $100,000 or more
- Running now
- 1 contract
- Biggest customer
- Office of Assistant Secretary for Preparedness and Response$89M on 1 contract
- Main industry
- Research and Development in Biotechnology (except Nanobiotechnology)NAICS 541714
- UEI
- SX5LJU3KWF93Unique entity ID in SAM.gov
- Source
- USAspending.govUpdated Nov 17, 2026, 7:02 PM UTC
Running contracts
Soonest end first. An agency may compete the work again, extend the contract or move it to another vehicle.
| Contract | Obligated | Ends | State |
|---|---|---|---|
| Advanced Research and Development of Rvsv-Marv Vaccine.Office of Assistant Secretary for Preparedness and Response · 75A50119C00022 | $89,026,883 | Jan 31, 2029in 26 months | MA |
End dates are the current period of performance; options not yet exercised can extend them. Each contract links to its record on USAspending.gov.
Who they work for
| Agency | Amount | Share |
|---|---|---|
| Office of Assistant Secretary for Preparedness and Response1 contract | $89,026,883 |
What they sell
| Industry | Amount | Share |
|---|---|---|
| Research and Development in Biotechnology (except Nanobiotechnology)NAICS 541714 · 1 contract | $89,026,883 |
Where the work is
| Place of work | Amount | Share |
|---|---|---|
| Massachusetts1 contract | $89,026,883 |
Source: USAspending.gov, prime contracts of $100,000 or more with an action since October 1, 2023. Department of Defense contracts appear there about 90 days after award. Other contracts ending soon at Office of Assistant Secretary for Preparedness and Response: see the list.
Get new notices like Public Health Vaccines's work
New contract opportunities under NAICS 541714, research and development in biotechnology (except nanobiotechnology), the morning they appear. Free while in beta.
Free. We use your email only for these alerts and never share it. Privacy